Structure and bonding of a radium coordination compound in the solid state.
Journal
Nature chemistry
ISSN: 1755-4349
Titre abrégé: Nat Chem
Pays: England
ID NLM: 101499734
Informations de publication
Date de publication:
09 Nov 2023
09 Nov 2023
Historique:
received:
13
03
2023
accepted:
11
10
2023
medline:
10
11
2023
pubmed:
10
11
2023
entrez:
9
11
2023
Statut:
aheadofprint
Résumé
The structure and bonding of radium (Ra) is poorly understood because of challenges arising from its scarcity and radioactivity. Here we report the synthesis of a molecular Ra
Identifiants
pubmed: 37945833
doi: 10.1038/s41557-023-01366-z
pii: 10.1038/s41557-023-01366-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
Références
McDevitt, M. R. et al. Tumor therapy with targeted atomic nanogenerators. Science 294, 1537–1540 (2001).
pubmed: 11711678
doi: 10.1126/science.1064126
Kratochwil, C. et al.
pubmed: 27390158
doi: 10.2967/jnumed.116.178673
Makvandi, M. et al. Alpha-emitters and targeted alpha therapy in oncology: from basic science to clinical investigations. Target. Oncol. 13, 189–203 (2018).
pubmed: 29423595
doi: 10.1007/s11523-018-0550-9
Thiele, N. A. & Wilson, J. J. Actinium-225 for targeted α therapy: coordination chemistry and current chelation approaches. Cancer Biother. Radiopharm. 33, 336–348 (2018).
pubmed: 29889562
pmcid: 6207149
Eychenne, R., Chérel, M., Haddad, F., Guérard, F. & Gestin, J. F. Overview of the most promising radionuclides for targeted alpha therapy: the ‘hopeful eight’. Pharmaceutics 13, 906 (2021).
pubmed: 34207408
doi: 10.3390/pharmaceutics13060906
pmcid: 8234975
Hu, A. & Wilson, J. J. Advancing chelation strategies for large metal ions for nuclear medicine applications. Acc. Chem. Res. 55, 904–915 (2022).
pubmed: 35230803
doi: 10.1021/acs.accounts.2c00003
pmcid: 9364011
Kluetz, P. G. et al. Radium (Ra-223) dichloride injection: U.S. food and drug administration drug approval summary. Clin. Cancer Res. 20, 9–14 (2014).
pubmed: 24190979
doi: 10.1158/1078-0432.CCR-13-2665
Parker, C. et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N. Engl. J. Med. 369, 213–223 (2013).
pubmed: 23863050
doi: 10.1056/NEJMoa1213755
Sartor, O. et al. Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. Lancet Oncol. 15, 738–746 (2014).
pubmed: 24836273
doi: 10.1016/S1470-2045(14)70183-4
Henriksen, G. et al. Targeting of osseous sites with α-emitting
pubmed: 12571218
Takalkar, A., Adams, S. & Subbiah, V. Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone. Exp. Hematol. Oncol. 3, 1–7 (2014).
doi: 10.1186/2162-3619-3-23
Marques, I. A. et al. Targeted alpha therapy using radium-223: from physics to biological effects. Cancer Treat. Rev. 68, 47–54 (2018).
pubmed: 29859504
doi: 10.1016/j.ctrv.2018.05.011
Chen, X., Ji, M., Fisher, D. R. & Wai, C. M. Ionizable calixarene-crown ethers with high selectivity for radium over light alkaline earth metal ions. Inorg. Chem. 38, 5449–5452 (1999).
doi: 10.1021/ic990135+
Henriksen, G., Hoff, P. & Larsen, R. H. Evaluation of potential chelating agents for radium. Appl. Radiat. Isot. 56, 667–671 (2002).
pubmed: 11993940
doi: 10.1016/S0969-8043(01)00282-2
Gott, M., Steinbach, J. & Mamat, C. The radiochemical and radiopharmaceutical applications of radium. Open Chem. 14, 118–129 (2016).
doi: 10.1515/chem-2016-0011
Freesmeyer, M., Weigand, W. & Weisheit, T. Examination of the complexation ability of different calixarene derivatives towards [
pubmed: 30551225
doi: 10.3413/Nukmed-0933-18-08
Riondato, M., Pastorino, S., Duce, V., Giovannini, E. & Ciarmiello, A. Comparative radium-223 labeling with NOTA- and DOTA-somatostatin derivatives for a potential use in targeted cancer therapy. Nucl. Med. Biol. 72–73, S50–S51 (2019).
doi: 10.1016/S0969-8051(19)30328-2
Abou, D. S. et al. Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand. Chem. Sci. 12, 3733–3742 (2021).
pubmed: 34163647
doi: 10.1039/D0SC06867E
pmcid: 8179459
Ivanov, A. S. et al. Elucidating the coordination chemistry of the radium ion for targeted alpha therapy. Chem. Commun. 58, 9938–9941 (2022).
doi: 10.1039/D2CC03156F
Shannon, R. D. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr. A 32, 751–767 (1976).
doi: 10.1107/S0567739476001551
Weigel, F. & Trinkl, A. Crystal chemistry of radium. I. Radium halides. Radiochim. Acta 9, 36–41 (1968).
doi: 10.1524/ract.1968.9.1.36
Weigel, F. & Trinkle, A. Crystal chemistry of radium. II. Radium salts of the RaXO4 type (X = sulfur, selenium, chromium, molybdenum, tungsten). Radiochim. Acta 9, 140–144 (1968).
doi: 10.1524/ract.1968.9.23.140
Weigel, F. & Trinkl, A. Crystal chemistry of radium. III. Preparation, crystal structure, and atomic radius of metallic radium. Radiochim. Acta 10, 78–82 (1968).
doi: 10.1524/ract.1968.10.12.78
Weigel, F. & Trinkl, A. Crystal chemistry of radium. IV. Radium sulfide and selenide. Radiochim. Acta 12, 29–31 (1969).
doi: 10.1524/ract.1969.12.1.29
Weigel, F. & Trinkl, A. On the crystal chemistry of radium V. Various radium salts of inorganic anions. Radiochim. Acta 19, 199–202 (1973).
doi: 10.1524/ract.1973.19.4.199
Matyskin, A. V., Ylmen, R., Lagerkvist, P., Ramebäck, H. & Ekberg, C. Crystal structure of radium sulfate: an X-ray powder diffraction and density functional theory study. J. Solid State Chem. 253, 15–20 (2017).
doi: 10.1016/j.jssc.2017.05.024
Stanjek, H. & Häusler, W. Basics of X-ray diffraction. Hyperfine Interact 154, 107–119 (2004).
doi: 10.1023/B:HYPE.0000032028.60546.38
Thiele, N. A. et al. An eighteen‐membered macrocyclic ligand for actinium‐225 targeted alpha therapy. Angew. Chem. Int. Ed. 129, 14904–14909 (2017).
doi: 10.1002/ange.201709532
Price, E. W. & Orvig, C. Matching chelators to radiometals for radiopharmaceuticals. Chem. Soc. Rev. 43, 260–290 (2014).
pubmed: 24173525
doi: 10.1039/C3CS60304K
Okoye, N. C., Baumeister, J. E., Khosroshahi, F. N., Hennkens, H. M. & Jurisson, S. S. Chelators and metal complex stability for radiopharmaceutical applications. Radiochim. Acta 107, 1087–1120 (2019).
doi: 10.1515/ract-2018-3090
Yang, H. et al. Harnessing alpha-emitting radionuclides for therapy: radiolabeling method review. J. Nucl. Med. 63, 5–13 (2021).
pubmed: 34503958
doi: 10.2967/jnumed.121.262687
Yamaguchi, A. et al. Extended X-ray absorption fine structure spectroscopy measurements and ab initio molecular dynamics simulations reveal the hydration structure of the radium(II) ion. iScience 25, 104763 (2022).
pubmed: 35992079
doi: 10.1016/j.isci.2022.104763
pmcid: 9386089
Bai, Z. et al. Radium revisited: revitalization of the coordination chemistry of nature’s largest +2 cation. Inorg. Chem. 62, 8478–8481 (2023).
pubmed: 37210659
doi: 10.1021/acs.inorgchem.3c01170
Bush, M. A. & Truter, M. R. Crystal structures of complexes between alkali-metal salts and cyclic polyethers. Part IV. The crystal structures of dibenzo-30-crown-10 (2,3:17,18-dibenzo-1,4,7,10,13,16,19,22,25,28-decaoxacyclotriaconta-2,17-diene) and of its complex with potassium iodide. J. Chem. Soc. Perkin Trans. 2, 345–350 (1972).
doi: 10.1039/p29720000345
Owen, J. D., Truter, M. R. & Wingfield, J. N. Reaction between dibenzo-30-crown-10 and potassium thiocyanate; structures of the 1:1 complexes, anhydrous and monohydrated, [K(C
doi: 10.1107/S0108270184008568
Li, Z., Xu, H., Wang, X. & Fan, Y. Crystal and molecular structure of dibenzo-30-crown-10-barium complex with bismuth trichloride. Jiegou 8, 273–277 (1989).
Fan, Y., Xu, H., Wei, Y. & Hu, Q. Crystal and molecular structure of [Ba(DB30C10)(H
White, F. D. et al. Molecular and electronic structure, and hydrolytic reactivity of a samarium(II) crown ether complex. Inorg. Chem. 58, 3457–3465 (2019).
pubmed: 30788962
doi: 10.1021/acs.inorgchem.8b03566
Cowie, B. E., Douair, I., Maron, L., Love, J. B. & Arnold, P. L. Selective oxo ligand functionalisation and substitution reactivity in an oxo/catecholate-bridged U
pubmed: 33033607
doi: 10.1039/D0SC02297G
pmcid: 7499863
Pettit, W. A. & Baenziger, N. C. Barium (cryptand-222B)Cl
doi: 10.1107/S0108270193009205
Rodriguez-Cruz, S. E., Jockusch, R. A. & Williams, E. R. Hydration energies and structures of alkaline earth metal ions, M
pubmed: 16429612
doi: 10.1021/ja9911871
pmcid: 1325212
Chekhlov, A. N. Crystal structure of the diaqua(1,10-diaza-18-crown-6)(tetrafluorosuccinato-O)barium complex. Russ. J. Coord. 28, 137–142 (2002).
doi: 10.1023/A:1014292320015
Chekhlov, A. N. Crystal structure of an unusual hydrated complex of 1,4,7,10,13-pentaoxacyclohexadecane-14,16-dione with calcium thiocyanate. Russ. J. Coord. 28, 163–169 (2002).
doi: 10.1023/A:1014767817232
Chekhlov, A. N. Twinned and disordered crystal structure of solvated bis[bqua(2.2.2-cryptand)calcium] hexa(isothiocyanato)calciate. Russ. J. Coord. 28, 454–460 (2002).
doi: 10.1023/A:1016288909060
Chekhlov, A. N. Crystal structure of diaqua(2.2.2-cryptand)strontium bis(thiocyanate). J. Struct. Chem. 43, 501–506 (2002).
doi: 10.1023/A:1020353503220
Simms, M. E. et al. Reining in radium for nuclear medicine: extra-large chelator development for an extra-large ion. Inorg. Chem. https://doi.org/10.1021/acs.inorgchem.3c02985 (2023).
doi: 10.1021/acs.inorgchem.3c02985
pubmed: 37811965
Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. C 71, 3–8 (2015).
doi: 10.1107/S2053229614024218
Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42, 339–341 (2009).
doi: 10.1107/S0021889808042726
Cary, S. K., Boland, K. S., Cross, J. N., Kozimor, S. A. & Scott, B. L. Advances in containment methods and plutonium recovery strategies that led to the structural characterization of plutonium(IV) tetrachloride tris-diphenylsulfoxide, PuCl
doi: 10.1016/j.poly.2017.01.013